BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15852021)

  • 1. Target accessibility dictates the potency of human RISC.
    Brown KM; Chu CY; Rana TM
    Nat Struct Mol Biol; 2005 May; 12(5):469-70. PubMed ID: 15852021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of a dinuclear ruthenium(ii) complex to the TAR region of the HIV-AIDS viral RNA.
    Buck DP; Spillane CB; Collins JG; Keene FR
    Mol Biosyst; 2008 Aug; 4(8):851-4. PubMed ID: 18633486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for target RNA recognition and cleavage by human RISC.
    Ameres SL; Martinez J; Schroeder R
    Cell; 2007 Jul; 130(1):101-12. PubMed ID: 17632058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome.
    Greco-Stewart VS; Miron P; Abrahem A; Pelchat M
    Virology; 2007 Jan; 357(1):68-78. PubMed ID: 16959288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the effects of target structure on siRNA efficiency.
    Chen J; Zhang W
    J Chem Phys; 2012 Dec; 137(22):225102. PubMed ID: 23249034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focusing on RISC assembly in mammalian cells.
    Hong J; Wei N; Chalk A; Wang J; Song Y; Yi F; Qiao RP; Sonnhammer EL; Wahlestedt C; Liang Z; Du Q
    Biochem Biophys Res Commun; 2008 Apr; 368(3):703-8. PubMed ID: 18252196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target site effects in the RNA interference and microRNA pathways.
    Obernosterer G; Tafer H; Martinez J
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1216-9. PubMed ID: 19021528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structure-based approach for targeting the HIV-1 genomic RNA dimerization initiation site.
    Ennifar E; Paillart JC; Bernacchi S; Walter P; Pale P; Decout JL; Marquet R; Dumas P
    Biochimie; 2007 Oct; 89(10):1195-203. PubMed ID: 17434658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology: the dance of domains.
    Puglisi JD
    Nature; 2007 Dec; 450(7173):1171-2. PubMed ID: 18097392
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
    Watrin M; Von Pelchrzim F; Dausse E; Schroeder R; Toulmé JJ
    Biochemistry; 2009 Jul; 48(26):6278-84. PubMed ID: 19496624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of RNA interference by adenovirus virus-associated RNA.
    Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
    J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
    Vo MN; Barany G; Rouzina I; Musier-Forsyth K
    J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.
    McKenna SA; Kim I; Liu CW; Puglisi JD
    J Mol Biol; 2006 May; 358(5):1270-85. PubMed ID: 16580685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of HIV TAR RNA-ligand complexes reveal higher binding stoichiometries.
    Ferner J; Suhartono M; Breitung S; Jonker HR; Hennig M; Wöhnert J; Göbel M; Schwalbe H
    Chembiochem; 2009 Jun; 10(9):1490-4. PubMed ID: 19444830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting RNA-interference pathway with small molecules.
    Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
    Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
    Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
    J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.